Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Document › Details

Goodwin Procter LLC. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock".

Organisations Organisation Goodwin Procter LLP
  Group Goodwin Procter (Goowin Law) (Group)
  Organisation 2 Intellia Therapeutics Inc. (Nasdaq: NTLA)
Products Product legal services
  Product 2 CRISPR gene editing technology
Person Person McGivern, Arthur R. (Art) (Goodwin Procter 201711 Partner)

The Life Sciences team advised Intellia Therapeutics, Inc.(Nasdaq:NTLA), on the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a public offering price of $24.00 per share, before underwriting discounts. Intellia also granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock. The gross proceeds from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be $150 million, excluding any exercise of the underwriters’ option to purchase additional shares.

Goodwin has a long-standing relationship with Intellia Therapeutics since its formation in 2014, through major collaborations with Novartis and Regeneron and last year’s $108 million IPO and $55 million simultaneous private placement, which is considered among the most successful biotech IPOs of 2016.

Intellia Therapeutics is a leading genome editing company focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system.

The Goodwin cross disciplinary team was led by partner Art McGivern and included partners William Collins, Janet Andolina, Scott Lassman and Martin Carmichael; and associates Gabriela Morales-Rivera and Riley Lovendale.

For more information on the offering, please read the press release.

Related Professionals

Arthur R. McGivern
William D. Collins
Janet Andolina
Scott Lassman
Martin Carmichael
Gabriela Morales-Rivera
Riley Lovendale

Record changed: 2017-11-19


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Goodwin Procter (Goowin Law) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top